Both in Pharmaceuticals
Xencor vs Immunome
Over the past year XNCR returned +113.9% and IMNM returned +7.1%; their daily moves had a correlation of 0.43.
XNCR +113.9% IMNM +7.1%Growth of $1, one year, split-adjusted
| Metric | XNCR | IMNM |
|---|---|---|
| Price | $29.82 | $18.21 |
| Market cap | $2.22B | $2.15B |
| Today | +2.09% | −0.44% |
| 1 month | +20.4% | −12.8% |
| 6 months | +135.0% | −19.9% |
| Year to date | +94.8% | −15.2% |
| 1 year | +103.3% | +15.5% |
| Revenue growth (YoY) | +17.5% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −42.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 21.1× | — |
| Net cash | $351.6M | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 62.4% | 55.6% |
| Short % of float | 17.0% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).